Abstract:
A method for the creation of endothelial parent vessels from human vascular endothelial cells in vitro in a culture perfusion device (CPD) including a collagen chamber, inlet ports, a capillary tube, and an outlet port. A collagen solution is injected into the collagen chamber through a syringe needle until the chamber is filled with collagen. The CPD is perfused by filling the inlet ports and sequentially priming the inlet ports, and the outlet ports. A perfusable channel is created in the collagen chamber and a concentrated suspension of endothelial cells is injected into the inlet ports. The endothelial cells are injected into the at least one perfusable channel and incubated to attach to the walls of the perfusable channel. The cells are distributed within the CPD; and perfused to form a parent vessel having homogeneous monolayers of cells.
Abstract:
The invention provides a catalyst system for catalytic fast pyrolysis comprising a cerium-incorporated HZSM-5 zeolite (Catalyst 1), and methods of making and using the same. The invention also provides a process for reducing coke formation during catalytic fast pyrolysis of biomass using HZSM-5, wherein the process can include incorporating cerium into the HZSM-5 zeolite to produce Catalyst 1 prior to the catalytic fast pyrolysis.
Abstract:
A process for preparing organopolysiloxanes by reacting linear siloxane compounds (II) and/or cyclic siloxane compounds (III) with a compound having at least one hydroxyl group R′—OH (IV) where R′ are identical or different organic radicals, which is characterized in that the compounds of the formulae (II), (III) and (IV) are used in such amounts that the molar ratio of silicon atoms in the compounds of the formulae (II) and (III) to OH groups in the compounds of the formula (IV) is from 0.01:1 to 1000:1, and in that the reaction is performed at a temperature of greater than 70° C. to 175° C., and in that the resulting reaction mixture is not treated with an acidic compound.
Abstract:
The invention provides a process for preparing SiOC-bonded polyorganosiloxanes by reacting, by processes known per se, hydroxyl-containing compounds with a stoichiometric excess of polyorganosiloxanes which contain —Si(H) units and are of the general formula (I) in the presence of one or more element compounds of main group III and/or of transition group 3 as a catalyst, wherein the reaction, on completion of conversion of the compounds containing hydroxyl groups, is continued until no further ≡Si—H groups are detectable by gas volumetric means, and also the compounds prepared in this way and their use.
Abstract:
Creating a tissue structure in vitro includes juxtaposing mandrels on a culture/perfusion device frame where the mandrels are spaced apart substantially parallel to each other and connecting the mandrels to tubes including an upstream tubes and downstream tubes. The upstream tubes are connected with an upstream manifold and the downstream tubes are connected to a downstream manifold. The frame and the mandrels are sterilized, coated and seeded with cells that multiply and form circular layers around each of the mandrels until the circular layers merge into a tissue structure which is subjected to a growth medium. The mandrels are extracted and the tissue structure is perfused.
Abstract:
The invention relates to a hydraulic binding agent comprising a binding agent component having free-flowing or solidifying properties when water is added and an acceleration component which is used to accelerate solidification. The acceleration component contains ultrafine calcium hydroxide having a high specific surface and low grain size.
Abstract:
The invention relates to a process for the treatment of polyoxyalkylene-polysiloxane block copolymers or alkylpolysiloxane-polyoxyalkylenepolysiloxane block copolymers in which the polysiloxane blocks are bonded to the polyether blocks or alkyl radicals by SiC bonds, wherein the polyoxyalkylene-polysiloxane block copolymers or alkylpolysiloxane-polyoxyalkylenepolysiloxane block copolymers or the solutions thereof are treated with flowing hydrogen gas and optionally a further inert gas in the presence of a combination of hydrogenation catalysts known per se and acid-activated carrier materials and water at temperatures of from 20 to 200° C. and atmospheric pressure over a period of from 0.5 to 10 hours.
Abstract:
Microvessel networks are produced in vitro from tissue-engineered parent vessels sprouting into a supporting matrix, as for example gels, of extracellular matrix proteins. The microvessel systems are integrated into devices that allow for controlled perfusion with fluids. The vessels may include cells from one cell type, for example, endothelial cells, or from combinations of two or more cell types.
Abstract:
Provided is a method for characterizing a polypeptide, which method comprises the steps of: (a) optionally reducing cysteine disulphide bridges in the polypeptide to form free thiols, and capping the free thiols; (b) cleaving the polypeptide with a sequence specific cleavage reagent to form peptide fragments; (c) optionally deactivating the cleavage reagent; (d) capping one or more ε-amino groups that are present with a lysine reactive agent; (e) analyzing peptide fragments by mass spectrometry to form a mass fingerprint for the polypeptide; and (f) determining the identity of the polypeptide from the mass fingerprint.
Abstract:
The invention relates to a catalytic system for the dehydrogenative condensation of polyorganosiloxanes with alcohols, consisting of at least one boron compound and at least one synergistically active compound, and to a process for converting polyorganosiloxanes, in which one hydrogen atom bonded to the silicon is replaced by an alkoxide radical using the inventive catalytic system.